Nitric oxide signaling during myocardial angiogenesis

Molecular and Cellular Biochemistry

Volumn 264, Issue 1-2, 2004, Pages 25-34

  Kondo, Takahisa ^a   Kobayashi, Koichi ^a   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Coronary risk factors; Endothelium; Ischemia; Nitric oxide

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ARGININE; CALCIUM; CALMODULIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SUBSTANCE P; TETRAHYDROBIOPTERIN; UNINDEXED DRUG; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; WORTMANNIN;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY RISK; GENE TRANSFER; HEART FAILURE; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; PERINATAL PERIOD; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIOSCLEROSIS; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; HEART; HEART DISEASES; HUMANS; MODELS, BIOLOGICAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 5544319199     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000044371.06317.0a     Document Type: Review

References (107)

1. Schaper W, Sharma HS, Quinkler W, Markert T, Wunsch M, Schaper J: Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol 15: 513-518, 1990
2. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK: Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation 102: E73-E86, 2000
3. Schaper W: Control of coronary angiogenesis. Eur Heart J 16(suppl C): 66-68, 1995
4. Waltenberger J: Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49: 554-560, 2001
5. Scheel KW, Williams SE: Hypertrophy and coronary and collateral vascularity in dogs with severe chronic anemia. Am J Physiol 249: H1031-H1037, 1985
6. Olivetti G, Lagrasta C, Quaini F, Ricci R, Moccia G, Capasso JM, Anversa P: Capillary growth in anemia-induced ventricular wall remodeling in the rat heart. Circ Res 65: 1182-1192, 1989
7. Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM, Kuntz RE: Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105: 2012-2018, 2002
8. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM: Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998
9. Hood JD, Meininger CJ, Ziche M, Granger HJ: VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 274: H1054-H1058, 1998
10. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993
11. Sessa WC: The nitric oxide synthase family of proteins. J Vasc Res 31: 131-143, 1994
12. Palmer RM, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988
13. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980
14. Rapoport RM, Draznin MB, Murad F: Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 306: 174-176, 1983
15. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989
16. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H: Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23: 1121-1131, 1994
17. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995
18. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O: Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93: 13176-13181, 1996
19. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997
20. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13: 18-32, 1992
21. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M: Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270: H411-H415, 1996
22. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC: Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997
23. Ku DD, Zaleski JK, Liu S, Brock TA: Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265: H586-H592, 1993
24. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM: Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95: 1030-1037, 1997
25. Hariawala MD, Horowitz JR, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM, Symes JF: VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63: 77-82, 1996
26. Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Losordo DW, Hendel RC, Bonow RO, Eppler SM, Zioncheck TF, Holmgren EB, McCluskey ER: Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 142: 872-880, 2001
27. Matsunaga T, Weihrauch DW, Moniz MC, Tessmer J, Warltier DC, Chilian WM: Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 105: 2185-2191, 2002
28. Tsurunu Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner JM: Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 3: 879-886, 1997
29. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM: Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97: 99-107, 1998
30. Jingling L, Srinivasan B, Bian X, Downey HF, Roque RS: Vascular endothelial growth factor is increased following coronary artery occlusion in the dog heart. Mol Cell Biochem 214: 23-30, 2000
31. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM: Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102: 3098-3103, 2000
32. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 138: 213-221, 1991
33. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM: Vascular endothelial growth factor-C (VEGF-CNEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153: 381-394, 1998
34. He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB: Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 274: 25130-25135, 1999
35. Kroll J, Waltenberger J: VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commum 252: 743-746, 1998
36. Lee PC, Salyapongse AN, Bragdon GA, Shears LL, II, Watkins SC, Edington HD, Billiar TR: Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 277: H1600-H1608, 1999
37. Zhao X, Lu X, Feng Q: Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis. Am J Physiol Heart Circ Physiol 283: H2371-H2378, 2002
38. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989
39. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989
40. Gooch KJ, Dangler CA, Frangos JA: Exogenous, basal, and flow-induced nitric oxide production and endothelial cell proliferation. J Cell Physiol 171: 252-258, 1997
41. Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M: Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 91: 25-31, 2002
42. Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I, Mattot V, Perriard JC, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA, Shima DT: Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5: 495-502, 1999
43. Kliche S, Waltenberger J: VEGF receptor signaling and endothelial function. IUBMB Life 52: 61-66, 2001
44. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, Galeotti T: Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 277: 3101-3108, 2002
45. Waltenberger J, Claesson-Welsh L, Siegbahn A, Slubuya M, Heldin CH: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988-26995, 1994
46. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98: 2018-2026, 1996
47. Franke TF, Kaplan DR, Cantley LC: PI3K: Downstream AKTion blocks apoptosis. Cell 88: 435-437, 1997
48. Khwaja A: Akt is more than just a Bad kinase. Nature 401: 33-34, 1999
49. Fujio Y, Walsh K: Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 274: 16349-16354, 1999
50. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273: 30336-30343, 1998
51. Oikawa T, Shimamura M: Potent inhibition of angiogenesis by wortmannin, a fungal metabolite. Eur J Pharmacol 318: 93-96, 1996
52. Shiojima I, Walsh K: Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90: 1243-1250, 2002
53. Jiang BH, Zheng JZ, Aoki M, Vogt PK: Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A 97: 1749-1753, 2000
54. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98: 894-898, 1996
55. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999
56. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999
57. Six I, Kureishi Y, Luo Z, Walsh K: Akt signaling mediates VEGF/VPF vascular permeability in vivo. FEBS Lett 532: 67-69, 2002
58. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA: Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4: 915-924, 1999
59. Suarez S, Ballmer-Hofer K: VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci 114: 1229-1235, 2001
60. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, Ziche M: Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 273: 4220-4226, 1998
61. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, Losordo DW, Isner JM: Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 19: 1156-1161, 1999
62. Noiri E, Hu Y, Bahou WE, Keese CR, Giaever I, Goligorsky MS: Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem 272: 1747-1752, 1997
63. Lau YT, Ma WC: Nitric oxide inhibits migration of cultured endothelial cells. Biochem Biophys Res Commun 221: 670-674, 1996
64. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P, Maragoudakis ME: Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902, 1994
65. Steudel W, Ichinose F, Huang PL, Hurford WE, Jones RC, Bevan JA, Fishman MC, Zapol WM: Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res 81: 34-41, 1997
66. Kimura H, Ogura T, Kurashima, Y, Weisz A, Esumi H: Effects of nitric oxide donors on vascular endothelial growth factor gene induction. Biochem Biophys Res Commun 296: 976-982, 2002
67. Dulak J, Jozkowicz A: Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies. Antioxid Redox Signal 5: 123-132, 2003
68. Shen YH, Wang XL, Wilcken DE: Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett 433: 125-131, 1998
69. Lopez-Farre A, Sanchez de Miguel L, Caramelo C, Gomez- Macias J, Garcia R, Mosquera JR, de Frutos T, Millas I, Rivas F, Echezarreta G, Casado S: Role of nitric oxide in autocrine control of growth and apoptosis of endothelial cells. Am J Physiol 272: H760-H768, 1997
70. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A, Dimmeler S: Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 274: 6823-6826, 1999
71. Hirschi KK, D'Amore PA: Pericytes in the microvasculature. Cardiovascc Res 32: 687-698, 1996
72. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH: Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 79: 748-756, 1996
73. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM: Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91: 2802-2809, 1995
74. Arnet UA, McMillan A, Dinerman JL, Ballermann B, Lowenstein CJ: Regulation of endothelial nitric-oxide synthase during hypoxia. J Biol Chem 271: 15069-15073, 1996
75. Meininger CJ, Schelling ME, Granger HJ: Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 255: H554-H562, 1988
76. Arnal JF, Yamin J, Dockery S, Harrison DG: Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am J Physiol 267: C1381-C1388, 1994
77. Kanazawa K, Kawashima S, Mikami S, Miwa Y, Hirata K, Suematsu M, Hayashi Y, Itoh H, Yokoyama M: Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol 148: 1949-1956, 1996
78. Shimokawa H, Flavahan NA, Vanhoutte PM: Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res 65: 740-753, 1989
79. Freedman SB, Isner JM: Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136: 54-71, 2002
80. Khurana R, Martin JF, Zachary I: Gene therapy for cardiovascular disease: A case for cautious optimism. Hypertension 38: 1210-1216, 2001
81. Laham RJ, Simons M, Tofukuji M, Hung D, Sellke FW: Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: Insight into ischemia-induced reduction in endothelium-dependent vasodilatation. J Thorac Cardiovasc Surg 116: 1022-1028, 1998
82. Piatti P, Fragasso G, Monti LD, Caumo A, Van Phan C, Valsecchi G, Costa S, Fochesato E, Pozza G, Pontiroli AE, Chierchia S: Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: Comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol 34: 1452-1460, 1999
83. Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC: Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95: 2068-2074, 1997
84. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A: Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 328: 1659-1664, 1993
85. Cooke JP: Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20: 2032-2037, 2000
86. Jang JJ, Ho HK, Kwan HH, Fajardo LF, Cooke JP: Angiogenesis is impaired by hypercholesterolemia: Role of asymmetric dimethylarginine. Circulation 102: 1414-1419, 2000
87. Couffinhal T, Silver M, Kearney M, Sullivan A, Witzenbichler B, Magner M, Annex B, Peters K, Isner JM: Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 99: 3188-3198, 1999
88. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP: L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90: 1248-1253, 1992
89. Duan J, Murohara T, Ikeda H, Katoh A, Shintani S, Sasaki K, Kawata H, Yamamoto N, Imaizumi T: Hypercholesterolemia inhibits angiogenesis in response to lundlimb ischemia: Nitric oxide-dependent mechanism. Circulation 102: III370-376, 2000
90. Schwartz L: Amelioration of microvascular angina with arginine supplementation. Ann Intern Med 138: 160, 2003
91. Jozkowicz A, Cooke JP, Guevara I, Huk I, Funovics P, Pachinger O, Weidinger F, Dulak J: Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 51: 773-783, 2001
92. Takeshita S, Pu LQ, Stein LA, Sniderman AD, Bunting S, Ferrara N, Isner JM, Symes JF: Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90: II228-II234, 1994
93. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM: Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98: 2800-2804, 1998
94. Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M, Isner JM: Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68: 830-836; discussion 836-837, 1999
95. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM: Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93: 662-670, 1994
96. Amano K, Matsubara H, Iba O, Okigaki M, Fujiyama S, Imada T, Kojima H, Nozawa Y, Kawashima S, Yokoyama M, Iwasaka T: Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 41: 156-162, 2003
97. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K: The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6: 1004-1010, 2000
98. Behrendt D, Ganz P: Endothelial function. From vascular biology to clinical applications. Am J Cardiol 90: 40L-48L, 2002
99. Egashira K: Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Circ J 66: 529-533, 2002
100. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, Isner JM: Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 96: 2667-2674, 1997
101. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG: Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 58: 783-789, 1986
102. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC: Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 99: 1873-1879, 1997
103. Takeshita S, Tomiyama, H, Yokoyama N, Kawamura Y, Furukawa T, Ishigai Y, Shibano T, Isshiki T, Sato T: Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 52: 314-320, 2001
104. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM: Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154: 355-363, 1999
105. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A: Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99: 2239-2242, 1999
106. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM: Age-dependent impairment of angiogenesis. Circulation 99: 111-120, 1999
107. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, Luscher TF: Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98: 899-905, 1996